Cormorant Asset Management’s Keros Therapeutics KROS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-100,000
| Closed | -$4.8M | – | 79 |
|
|
2022
Q4 | $4.8M | Hold |
100,000
| – | – | 0.32% | 57 |
|
|
2022
Q3 | $3.76M | Hold |
100,000
| – | – | 0.26% | 53 |
|
|
2022
Q2 | $2.76M | Hold |
100,000
| – | – | 0.21% | 59 |
|
|
2022
Q1 | $5.44M | Sell |
100,000
-50,000
| -33% | -$2.72M | 0.42% | 49 |
|
|
2021
Q4 | $8.78M | Buy |
+150,000
| New | +$8.78M | 0.52% | 46 |
|